Ann Pharmacother

1. MARTIN-YEVES S, Colon-Lopez de Dicastillo A, Riancho J, Sanchez-de la Torre JR, et al
   Erenumab and Galcanezumab for Chronic Migraine Refractory to OnabotulinumtoxinA: A Real-World Comparative Study.
   Ann Pharmacother. 2026 Apr 14:10600280261429460. doi: 10.1177/10600280261429460.
   

   >> Share

   
   

   
   BMC Neurol

2. AN YC, Liang CS, Tsai CK, Tsai CL, et al
   Genome-wide association analysis of treatment response to onabotulinumtoxinA in Han Chinese patients with chronic migraine: a pilot study.
   BMC Neurol. 2026 Apr 15. doi: 10.1186/s12883-026-04878.
   

   >> Share

   
   

   
   Cephalalgia

3. FANI M, Sharp N, Schwedt TJ
   Reducing light sensitivity during and between migraine attacks: A prospective study investigating spectral tuning of white light.
   Cephalalgia. 2026;46:3331024261439257.
   

   >> Share

   
   
4. MARTIN PR
   How do we facilitate individuals with recurrent headache and migraine receiving evidence-based behavioral treatment?
   Cephalalgia. 2026;46:3331024261439266.
   

   >> Share

   
   

   
   Headache

5. ORR SL
   Retrofitted adult interventions aren't good enough: Why children and adolescents deserve tailored evidence-based care for migraine in the emergency department.
   Headache. 2026 Apr 10. doi: 10.1111/head.70092.
   

   >> Share

   
   

   
   Neurology

6. PELES I, Novack L, Gordon M, Sarov B, et al
   Acute Environmental Triggers and Intermediate-Term Modulators of Emergency Migraine-Related Health Care Encounters.
   Neurology. 2026;106:e214936.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share